Showing results (111-120 of 520) with videos related to
Sort By:
Pageof 52
The Journal of Investigative Dermatology|April 8, 2011
Inhibition of glycogen synthase kinase-3 increases the cytotoxicity of enzastaurinMark A Rovedo, Nancy L Krett, Steven T RosenExpert Opinion on Emerging Drugs|March 2, 2022
Emerging drugs for the treatment of cutaneous T-cell lymphomaMelissa Cheng, Jasmine Zain, Steven T Rosen, et al.Current Opinion in Oncology|August 27, 2010
Steroid receptor and microRNA regulation in cancerMichael A Tessel, Nancy L Krett, Steven T RosenArchives of Internal Medicine|August 1, 1988
Vibrio vulnificus septicemiaT J Hoffmann, B Nelson, R Darouiche, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1991
Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methodsJ A Sinkule, S T Rosen, J A RadosevichTumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1991
Expression of the epitope recognized by the monoclonal antibody 44-3A6 during human fetal developmentJ A Radosevich, S G Combs, S T RosenCell Insight|February 20, 2024
Function and mechanism of bispecific antibodies targeting SARS-CoV-2Zhaohui Li, Zengyuan Zhang, Steven T Rosen, et al.Cancer Treatment and Research|January 1, 2019
CD30-Positive Lymphoproliferative DisordersLiana Nikolaenko, Jasmine Zain, Steven T Rosen, et al.International Journal of Dermatology|October 1, 1980
Ultrastructural features of chromoblastomycosisT Rosen, F Gyorkey, L M Joseph, et al.Archives of Dermatology|October 1, 1987
Treatment of pediculosis pubis. Clinical comparison of efficacy and tolerance of 1% lindane shampoo vs 1% permethrin creme rinseD C Kalter, J Sperber, T Rosen, et al.Pageof 52